Matches in Wikidata for { <http://www.wikidata.org/entity/Q64600007> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- Q64600007 description "clinical trial" @default.
- Q64600007 description "ensayu clínicu" @default.
- Q64600007 description "klinisch onderzoek" @default.
- Q64600007 description "клінічне випробування" @default.
- Q64600007 name "Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes" @default.
- Q64600007 type Item @default.
- Q64600007 label "Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes" @default.
- Q64600007 prefLabel "Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes" @default.
- Q64600007 P1050 Q64600007-9B900622-F8A5-4D68-B39C-467D3BE83051 @default.
- Q64600007 P1132 Q64600007-88B8C18F-039C-4236-B33A-7F30F7EFD0D2 @default.
- Q64600007 P1476 Q64600007-D0F34A59-B419-4214-8ED9-F9B8208E5DB7 @default.
- Q64600007 P17 Q64600007-15A9CF12-1084-4D66-9CEF-43CEE2FD7051 @default.
- Q64600007 P17 Q64600007-20D64B46-D29D-4D6A-8058-DD26316E291E @default.
- Q64600007 P17 Q64600007-95C46CA5-587A-4B86-A760-B16185DB258A @default.
- Q64600007 P17 Q64600007-A66BDD5E-3314-4BB6-A5E9-5C3B2E1F0560 @default.
- Q64600007 P17 Q64600007-BE6A6814-689C-44E5-9EB3-F47B9AF6267E @default.
- Q64600007 P17 Q64600007-D00FB1AF-F3C9-45B0-9E98-F7D084D235D7 @default.
- Q64600007 P17 Q64600007-D4E4365D-1EA4-43B9-92B5-74DE82E12AAF @default.
- Q64600007 P17 Q64600007-DA7C2E6D-412B-4B28-8F37-FE712F841693 @default.
- Q64600007 P17 Q64600007-FBA5BD3E-75BE-4F4F-8F3E-2C33C8AE6D59 @default.
- Q64600007 P2899 Q64600007-06558294-9B2E-4217-8488-E546A16B1836 @default.
- Q64600007 P3098 Q64600007-C5ECE671-91CD-4A57-AADB-6AA38310A72D @default.
- Q64600007 P31 Q64600007-332CDA63-53ED-4D57-95C1-394A007BFC2A @default.
- Q64600007 P580 Q64600007-810BA4F4-134F-4A0A-BB05-12DFFB00726F @default.
- Q64600007 P582 Q64600007-1A28396A-8F9B-4FA4-B0BF-110EF15B57A9 @default.
- Q64600007 P6099 Q64600007-7DF7DFBF-D3E9-4904-835F-AEE304110A3B @default.
- Q64600007 P6153 Q64600007-15216C67-81A3-4F73-A84B-A3F4089EBFEA @default.
- Q64600007 P6153 Q64600007-199EBD5B-E402-45A3-A807-E5BF321A61B6 @default.
- Q64600007 P6153 Q64600007-39504458-7254-45C2-8BA2-405C53FF8C61 @default.
- Q64600007 P6153 Q64600007-44F556C7-4813-4E51-B46C-4C88DC500A4C @default.
- Q64600007 P6153 Q64600007-45C62FCC-E98C-4822-95C0-27CF1B1742B0 @default.
- Q64600007 P6153 Q64600007-5CD9D1E2-3C3E-4A20-93EB-1C600EA46549 @default.
- Q64600007 P6153 Q64600007-60CC04AC-B738-404D-BB29-2B800FDD08F7 @default.
- Q64600007 P6153 Q64600007-6670DA00-1449-4897-AA04-A7CFE63EA4F1 @default.
- Q64600007 P6153 Q64600007-690E85BA-2F83-480D-A598-A2A6CD347DF8 @default.
- Q64600007 P6153 Q64600007-69A78CF5-2B62-49E5-99D8-24CE850D7B81 @default.
- Q64600007 P6153 Q64600007-94A01C0E-4EFE-46CA-8BB3-E22BB6CB0447 @default.
- Q64600007 P6153 Q64600007-A5C5D043-69CC-4E22-BD4B-DCF4663667B4 @default.
- Q64600007 P6153 Q64600007-B4E364F9-1807-4A44-A755-052BB2860066 @default.
- Q64600007 P6153 Q64600007-C3FBD122-16A4-43EA-8D05-81E80E41E097 @default.
- Q64600007 P6153 Q64600007-C43E04EA-E22C-4100-AB54-64B03F4135F3 @default.
- Q64600007 P6153 Q64600007-D20F0AAA-AA12-4BEA-A68B-CF7111AF0A24 @default.
- Q64600007 P6153 Q64600007-D31B6B48-465D-4D57-981E-E70B46E9F68F @default.
- Q64600007 P6153 Q64600007-DD8BCC9E-35C1-4E79-87E9-335D00241836 @default.
- Q64600007 P6153 Q64600007-F3439195-E981-4514-AACA-9E7558B759D6 @default.
- Q64600007 P8363 Q64600007-6895C74F-DFD0-414E-BDA5-6ACA2DC43E9C @default.
- Q64600007 P1050 Q179630 @default.
- Q64600007 P1132 "+66" @default.
- Q64600007 P1476 "A Phase 2, International, Multicenter, Randomized, Open-label, Parallel Group to Evaluate the Efficacy and Safety of Cc-486 (Oral Azacitidine) Alone in Combination With Durvalumab (MEDI4736) in Subjects With Myelodysplastic Syndromes Who Fail to Achieve an Objective Response to Treatment With Azacitidine for Injection or Decitabine" @default.
- Q64600007 P17 Q142 @default.
- Q64600007 P17 Q145 @default.
- Q64600007 P17 Q183 @default.
- Q64600007 P17 Q29 @default.
- Q64600007 P17 Q30 @default.
- Q64600007 P17 Q31 @default.
- Q64600007 P17 Q36 @default.
- Q64600007 P17 Q38 @default.
- Q64600007 P17 Q408 @default.
- Q64600007 P2899 "+18" @default.
- Q64600007 P3098 "NCT02281084" @default.
- Q64600007 P31 Q30612 @default.
- Q64600007 P580 "2015-07-06T00:00:00Z" @default.
- Q64600007 P582 "2018-12-15T00:00:00Z" @default.
- Q64600007 P6099 Q42824440 @default.
- Q64600007 P6153 Q127773 @default.
- Q64600007 P6153 Q1517021 @default.
- Q64600007 P6153 Q193196 @default.
- Q64600007 P6153 Q1950740 @default.
- Q64600007 P6153 Q2496392 @default.
- Q64600007 P6153 Q30293350 @default.
- Q64600007 P6153 Q3145371 @default.
- Q64600007 P6153 Q49112 @default.
- Q64600007 P6153 Q49117 @default.
- Q64600007 P6153 Q5637237 @default.
- Q64600007 P6153 Q5902584 @default.
- Q64600007 P6153 Q6031854 @default.
- Q64600007 P6153 Q6806307 @default.
- Q64600007 P6153 Q7060443 @default.
- Q64600007 P6153 Q7373582 @default.
- Q64600007 P6153 Q7569131 @default.
- Q64600007 P6153 Q7989074 @default.
- Q64600007 P6153 Q87762406 @default.
- Q64600007 P6153 Q913126 @default.
- Q64600007 P8363 Q78089383 @default.